Clues To The Cause Of Difficulty With Swallowing In Children

Eosinophilic oesophagitis (EE) is disease that was first described in children only 20 years ago, but has shown a rising incidence in both children and adults. An inflammatory condition of the oesophagus, its symptoms including vomiting, heartburn and difficulty in swallowing.

In findings published on line January 10, 2007 in the Journal of Allergy & Clinical Immunology, researchers at the University of California, San Diego (UCSD) School of Medicine and Rady Children's Hospital and Health Centre, San Diego show that the disease causes many of the same kinds of tissue changes seen in paediatric asthma. Their research may lead to new drug targets for EE, which appears to be allergy-driven in some patients. The oesophagus is the soft tube-like portion of the digestive tract that leads from the back of the mouth to the stomach. In patients with EE, the disease leads to scarring and narrowing of the oesophagus, so that food can't readily pass through it. "We set out to find whether the kind of structural changes seen in other long-standing inflammatory diseases like childhood asthma also occur in EE," said Seema Aceves, M.D., Ph.D., of UCSD's Allergy Immunology section of the Department of Paediatrics. Aceves is also a physician at Rady Children's Hospital in San Diego and directs a treatment centre for children with eosinophilic gastrointestinal disorders. The research team studied biopsies of the oesophagus from children with an initial diagnosis of EE who had not yet been treated, comparing them to biopsies of children with acid reflux disease as well as those of children with normal oesophageal biopsies. "We found fibrosis, or scarring, as well as remodelling of the oesophagus in paediatric EE patients which is similar to airway remodelling found in patients with asthma," said Aceves. Remodelling occurs in chronic inflammatory diseases such as asthma and results in alterations in structural cells and tissues not found in normal tissues. The UCSD study showed that children with EE were found to have previously unrecognized changes to their oesophagus, including an increased number of blood vessels in the sub-epithelium, the region below the surface of the interior lining of the oesophagus. There were also a larger number of adhesion molecules present in these blood vessels, which cause the vessel wall to become sticky. As a result, allergy cells adhere to the sticky vessels and are then able to cross the blood barrier, resulting in inflammation in the oesophagus. These studies - performed by Aceves through an ongoing collaboration with the laboratory of David Broide, M.B. Ch.B., professor of medicine at UCSD School of Medicine and an expert in airway remodelling in asthma - identified three molecules that contribute to these changes in the oesophagus, and could provide new therapeutic targets for EE. Their data suggests that increased expression of the molecules TGF-beta 1, phospohrylated-SMAD2/3, and VCAM-1 may be involved in remodelling that leads to scarring and narrowing of the oesophagus. These molecules may serve as markers to provide physicians with a basis for predicting disease severity.(Source: Journal of Allergy & Clinical Immunology : University of California, San Diego : February 2007.)